179 related articles for article (PubMed ID: 20144347)
1. Gastric electrical stimulation with the TANTALUS System in obese type 2 diabetes patients: effect on weight and glycemic control.
Sanmiguel CP; Conklin JL; Cunneen SA; Barnett P; Phillips EH; Kipnes M; Pilcher J; Soffer EE
J Diabetes Sci Technol; 2009 Jul; 3(4):964-70. PubMed ID: 20144347
[TBL] [Abstract][Full Text] [Related]
2. Improvement in glycemic control by gastric electrical stimulation (TANTALUS) in overweight subjects with type 2 diabetes.
Bohdjalian A; Ludvik B; Guerci B; Bresler L; Renard E; Nocca D; Karnieli E; Assalia A; Prager R; Prager G
Surg Endosc; 2009 Sep; 23(9):1955-60. PubMed ID: 19067068
[TBL] [Abstract][Full Text] [Related]
3. Improvement in glycemic control in morbidly obese type 2 diabetic subjects by gastric stimulation.
Bohdjalian A; Prager G; Rosak C; Weiner R; Jung R; Schramm M; Aviv R; Schindler K; Haddad W; Rosenthal N; Ludvik B
Obes Surg; 2009 Sep; 19(9):1221-7. PubMed ID: 19575272
[TBL] [Abstract][Full Text] [Related]
4. Treatment of type 2 diabetes using meal-triggered gastric electrical stimulation.
Policker S; Haddad W; Yaniv I
Isr Med Assoc J; 2009 Apr; 11(4):206-8. PubMed ID: 19603591
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Patients with Obese Type 2 Diabetes with Tantalus-DIAMOND® Gastric Electrical Stimulation: Normal Triglycerides Predict Durable Effects for at Least 3 Years.
Lebovitz HE; Ludvik B; Yaniv I; Schwartz T; Zelewski M; Gutterman DD;
Horm Metab Res; 2015 Jun; 47(6):456-62. PubMed ID: 25993254
[TBL] [Abstract][Full Text] [Related]
6. Gastric electrical stimulation: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(16):1-79. PubMed ID: 23074486
[TBL] [Abstract][Full Text] [Related]
7. A pilot study to compare meal-triggered gastric electrical stimulation and insulin treatment in Chinese obese type 2 diabetes.
Wong SK; Kong AP; Luk AO; Ozaki R; Ng VW; Lebovitz HE; Ng EK; Chan JC
Diabetes Technol Ther; 2015 Apr; 17(4):283-90. PubMed ID: 25710812
[TBL] [Abstract][Full Text] [Related]
8. Fasting plasma triglycerides predict the glycaemic response to treatment of type 2 diabetes by gastric electrical stimulation. A novel lipotoxicity paradigm.
Lebovitz HE; Ludvik B; Yaniv I; Haddad W; Schwartz T; Aviv R;
Diabet Med; 2013 Jun; 30(6):687-93. PubMed ID: 23323566
[TBL] [Abstract][Full Text] [Related]
9. The Effects of Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass on Japanese Patients with BMI < 35 kg/m
Seki Y; Kasama K; Yasuda K; Yokoyama R; Porciuncula JP; Kurokawa Y
Obes Surg; 2018 Aug; 28(8):2429-2438. PubMed ID: 29502278
[TBL] [Abstract][Full Text] [Related]
10. The TANTALUS system for obesity: effect on gastric emptying of solids and ghrelin plasma levels.
Sanmiguel CP; Haddad W; Aviv R; Cunneen SA; Phillips EH; Kapella W; Soffer EE
Obes Surg; 2007 Nov; 17(11):1503-9. PubMed ID: 18219779
[TBL] [Abstract][Full Text] [Related]
11. The effect of care intervention for obese patients with type II diabetes.
Jiang X; Fan X; Wu R; Geng F; Hu C
Medicine (Baltimore); 2017 Oct; 96(42):e7524. PubMed ID: 29049180
[TBL] [Abstract][Full Text] [Related]
12. Gastric stimulation in treatment in type 2 diabetes mellitus.
Zonca P; Hoppe C; Cambal M; Jacobi CA
Bratisl Lek Listy; 2014; 115(1):34-7. PubMed ID: 24471901
[TBL] [Abstract][Full Text] [Related]
13. Vagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus.
Shikora S; Toouli J; Herrera MF; Kulseng B; Zulewski H; Brancatisano R; Kow L; Pantoja JP; Johnsen G; Brancatisano A; Tweden KS; Knudson MB; Billington CJ
J Obes; 2013; 2013():245683. PubMed ID: 23984050
[TBL] [Abstract][Full Text] [Related]
14. Improvements in glucose metabolism and insulin sensitivity with a low-carbohydrate diet in obese patients with type 2 diabetes.
Krebs JD; Bell D; Hall R; Parry-Strong A; Docherty PD; Clarke K; Chase JG
J Am Coll Nutr; 2013; 32(1):11-7. PubMed ID: 24015695
[TBL] [Abstract][Full Text] [Related]
15. Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials.
Franz MJ; Boucher JL; Rutten-Ramos S; VanWormer JJ
J Acad Nutr Diet; 2015 Sep; 115(9):1447-63. PubMed ID: 25935570
[TBL] [Abstract][Full Text] [Related]
16. One-year experience with Tantalus: a new surgical approach to treat morbid obesity.
Bohdjalian A; Prager G; Aviv R; Policker S; Schindler K; Kretschmer S; Riener R; Zacherl J; Ludvik B
Obes Surg; 2006 May; 16(5):627-34. PubMed ID: 16687033
[TBL] [Abstract][Full Text] [Related]
17. Equivalent weight loss with marked metabolic benefit observed in a matched cohort with and without type 2 diabetes 12 months following gastric bypass surgery.
Yip K; Heinberg L; Giegerich V; Schauer PR; Kashyap SR
Obes Surg; 2012 Nov; 22(11):1723-9. PubMed ID: 22895804
[TBL] [Abstract][Full Text] [Related]
18. Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss.
Jacob S; Rabbia M; Meier MK; Hauptman J
Diabetes Obes Metab; 2009 Apr; 11(4):361-71. PubMed ID: 19207292
[TBL] [Abstract][Full Text] [Related]
19. Five-year effectiveness of bariatric surgery on disease remission, weight loss, and changes of metabolic parameters in obese patients with type 2 diabetes: A population-based propensity score-matched cohort study.
Wu T; Wong SKH; Law BTT; Grieve E; Wu O; Tong DKH; Leung DKW; Lam CLK; Wong CKH
Diabetes Metab Res Rev; 2020 Mar; 36(3):e3236. PubMed ID: 31912598
[TBL] [Abstract][Full Text] [Related]
20. Outcomes in weight loss, fasting blood glucose and glycosylated hemoglobin in a sample of 415 obese patients, included in the database of the European accreditation council for excellence centers for bariatric surgery with laparoscopic one anastomosis gastric bypass.
Carbajo MA; Jiménez JM; Castro MJ; Ortiz-Solórzano J; Arango A
Nutr Hosp; 2014 Nov; 30(5):1032-8. PubMed ID: 25365005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
